Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 57 peer-reviewed journal articles Updated
Rheumatology

The Guide to Pediatric Systemic Lupus Erythematosus (pSLE)

At a Glance

Pediatric systemic lupus erythematosus (pSLE) is a rare autoimmune disorder where a child's immune system mistakenly attacks healthy tissues. With modern 'Treat-to-Target' treatments and specialized care, the 10-year survival rate now exceeds 90%, allowing children to lead active, fulfilling lives.

Receiving a diagnosis of pediatric systemic lupus erythematosus (pSLE) for your child can be an overwhelming and frightening experience. You are likely facing complex medical terms, new medications, and a sudden shift in your family’s daily life.

This guide is designed to empower you with evidence-based information. It aims to translate the complexities of pSLE into clear, actionable knowledge so that you can become the best advocate for your child’s health.

What is pSLE?

Pediatric systemic lupus erythematosus (pSLE) is a rare but serious autoimmune disorder [1]. In a healthy immune system, specific cells act as defenders against foreign invaders like viruses and bacteria. In pSLE, these cells—such as B-cells and neutrophils—become confused and hyperactive, mistakenly attacking the body’s own healthy tissues [2][3]. While children and adolescents account for only about 15% to 20% of all lupus cases, the pediatric form of the disease tends to be more aggressive and requires specialized, proactive care [1][4].

Navigating This Guide

This resource is broken down into specific topics to help you understand every aspect of your child’s journey, from the initial diagnosis to long-term monitoring.

01

Understanding Your Child's Diagnosis: An Orientation to pSLE

Learn what a pediatric lupus (pSLE) diagnosis means for your child. Understand treatments, kidney risks, and why it differs from adult systemic lupus.

02

Symptoms & Warning Signs: Recognizing pSLE and MAS

Learn to recognize the early symptoms of pediatric lupus (pSLE) and the critical warning signs of Macrophage Activation Syndrome (MAS) in your child.

03

Diagnosis & Genetics: How pSLE is Identified

Learn how pediatric systemic lupus erythematosus (pSLE) is diagnosed. Understand diagnostic criteria, genetic testing for monogenic lupus, and renal biopsies.

04

Standard of Care Treatment: The Treat-to-Target Approach

Learn about the treat-to-target approach for pediatric lupus (pSLE). Understand standard treatments, medication goals, and how to minimize steroid use.

05

Organ Involvement: Navigating Lupus Nephritis and CNS Lupus

Learn about organ involvement in pediatric lupus (pSLE). Understand the signs, monitoring, and treatment of lupus nephritis (kidneys) and CNS lupus (brain).

06

Long-Term Monitoring & Quality of Life: Living with pSLE

Learn how to manage pediatric systemic lupus erythematosus (pSLE) long-term. Discover how to monitor for organ damage, cardiovascular risks, and mental health.

A Message of Hope

Despite the challenges of pSLE, the landscape of pediatric rheumatology has changed dramatically in recent years. With modern treatments, clear “Treat-to-Target” roadmaps, and dedicated medical teams, the 10-year survival rate for children with pSLE now exceeds 90% [5]. By understanding the disease, monitoring for early warning signs, and working closely with your specialists, you can help your child lead a fulfilling and active life.

Common questions in this guide

What is pediatric systemic lupus erythematosus (pSLE)?
Pediatric systemic lupus erythematosus is a rare autoimmune disorder in children and adolescents where the immune system mistakenly attacks healthy tissues. While it accounts for 15 to 20 percent of all lupus cases, it tends to be more aggressive than adult-onset lupus and requires specialized care.
What is the Treat-to-Target approach for pSLE?
Treat-to-Target is a modern medical strategy that aims to achieve clinical remission or low disease activity. Pediatric rheumatologists use specific medications, such as steroid-sparing drugs and biologics, to carefully control inflammation while trying to minimize long-term side effects.
Why does my child with pSLE need regular blood and urine tests?
Routine bloodwork and urine tests are essential because they allow doctors to monitor for silent inflammation that doesn't cause obvious symptoms. This systematic screening helps catch serious complications, like kidney involvement, early enough to prevent permanent organ damage.
What is the long-term outlook for a child with pSLE?
The long-term outlook for children with pSLE has improved dramatically in recent years. Thanks to modern medical treatments and dedicated pediatric rheumatology care, the ten-year survival rate now exceeds 90 percent.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Who is my primary point of contact if my child develops a fever or other urgent symptoms after hours?
  2. 2.What is our specific Treat-to-Target goal right now?
  3. 3.How often will my child need bloodwork and urine tests to monitor for silent inflammation?
  4. 4.Can you recommend a specialized pediatric rheumatology clinic or a support group for families like ours?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (5)
  1. 1

    The association between initial manifestations of childhood-onset systemic lupus erythematosus and the survival.

    Fatemi A, Matinfar M, Saber M, Smiley A

    International journal of rheumatic diseases 2016; (19(10)):974-980 doi:10.1111/1756-185X.12807.

    PMID: 26632491
  2. 2

    B Cells as a Therapeutic Target in Paediatric Rheumatic Disease.

    Wilkinson MGL, Rosser EC

    Frontiers in immunology 2019; (10()):214 doi:10.3389/fimmu.2019.00214.

    PMID: 30837988
  3. 3

    Biomarkers associating endothelial Dysregulation in pediatric-onset systemic lupus erythematous.

    Lee WF, Wu CY, Yang HY, et al.

    Pediatric rheumatology online journal 2019; (17(1)):69 doi:10.1186/s12969-019-0369-7.

    PMID: 31651352
  4. 4

    DNA Methylation Profiling Reveals Distinct Epigenetic Clusters and Suggests Epigenetic Patterns Associated With Sex and Disease Activity in Childhood-Onset Lupus.

    Casares-Marfil D, Kavrul Kayaalp G, Guliyeva V, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2026; (78(6)):1245-1257 doi:10.1002/art.70045.

    PMID: 41451519
  5. 5

    Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force.

    Smith EMD, Aggarwal A, Ainsworth J, et al.

    Annals of the rheumatic diseases 2023; (82(6)):788-798 doi:10.1136/ard-2022-223328.

    PMID: 36627168

This guide provides educational information about pediatric systemic lupus erythematosus (pSLE) and its management. It is not a substitute for professional medical advice, diagnosis, or treatment from your child's pediatric rheumatologist.

Get notified when new evidence is published on Pediatric systemic lupus erythematosus.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.